First Intraoperative System to Combine Quantifiable Limb Alignment and Soft Tissue Balancing for Surgeons during Total Knee Arthroplasty SUNRISE, FL--(Healthcare Sales & Marketing Network) - OrthoSensor™, Inc., the leader in intelligent orthopedics, tod...
Devices, Orthopaedic, FDA
OrthoSensor, VERASENSE Kneee System, knee replacement, limb alignment

Sales of SURE CHECK(R) HIV 1/2 Assay in Europe Anticipated by Q1 2014 MEDFORD, N.Y., June 18, 2013 -- (Healthcare Sales & Marketing Network) -- Chembio Diagnostics, Inc. (CEMI) a leader in point-of-care ("POC") diagnostic tests for infectious ...
Diagnostics, HIV/AIDS, Regulatory
Chembio Diagnostics, SURE CHECK HIV 1/2 Assay

IRVINE, Calif.--(Healthcare Sales & Marketing Network)--NeurOptics, Inc., the leading provider of devices that collect and process information from the human eye to facilitate medical decision-making, announced the appointment of William Worthen as preside...
Devices, Neurology, Monitoring, Personnel
NeurOptics, Pupillometer, Neurological Pupil index

Company Fully-Funded Through SFP Commercialization WIXOM, MI--(Healthcare Sales & Marketing Network) - Rockwell Medical (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD...
Biopharmaceuticals
Rockwell Medical Technologies, end-stage renal disease, chronic kidney disease

Sleep apnea screening and monitoring is important in the management of cardiovascular co-morbidities. MILAN--(Healthcare Sales & Marketing Network)--Sorin Group (SRN.MI), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of...
Devices, Cardiology, Product Launch
Sorin Group, REPLY 200, Sleep Apnea Monitoring, sleep apnea, pacemaker

THE WOODLANDS, Texas, June 18, 2013 -- (Healthcare Sales & Marketing Network) -- Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that John Northcott has jo...
Biopharmaceuticals, Personnel
Lexicon Pharmaceuticals

25 Patient-Years of Cumulative Utilization Across 25 Patients EDEN PRAIRIE, Minn., June 18, 2013 -- (Healthcare Sales & Marketing Network) -- Sunshine Heart, Inc. (SSH) today announced a major milestone for its flagship C-Pulse device. As of today, C-Pu...
Devices, Cardiology
Sunshine Heart, C-Pulse, heart failure, balloon counterpulsation

Patients show three-year freedom from atrial fibrillation, anti-arrhythmic drugs PRAGUE--(Healthcare Sales & Marketing Network)--A leading German cardiovascular heart center reported promising mid-term results for the surgical treatment of persistent at...
Devices, Cardiology
AtriCure, atrial fibrillation, Bipolar RF Ablation, catheter ablation

VANTAGE Study Interim Data Presented at International Congress of Parkinson's Disease and Movement Disorders in Sydney NATICK, Mass., June 18, 2013 -- (Healthcare Sales & Marketing Network) -- Patients with Parkinson's disease using the Boston Scientif...
Devices, Neurosurgery
Boston Scientific, Parkinson's disease, Vercise DBS, deep brain stimulation

TARRYTOWN, N.Y.--(Healthcare Sales & Marketing Network)--Today, Siemens Healthcare Diagnostics announces its entrance into a collaboration with Janssen Pharmaceutica NV to design, develop and commercialize a companion diagnostic test associated with an ear...
Diagnostics, Personalized Medicine, Cardiology
Siemens Healthcare, Janssen Pharmaceutica, heart failure

Company Also Provides Update on Sandoz ANDA/Paragraph IV Trial Date ALAMEDA, Calif.--(Healthcare Sales & Marketing Network)--InSite Vision Incorporated (INSV) today announced that it will join Merck (MRK), known as MSD outside the United States (U.S.) a...
Biopharmaceuticals, Ophthalmology, Generics, Litigation
InSite Vision, Merck, Pfizer, Mylan Pharmaceuticals, AzaSite, azithromycin

Late-Stage Prostate Cancer Treatment Strengthens Oncology Pipeline NEW BRUNSWICK, N.J., June 17, 2013 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson (JNJ) announced today a definitive agreement to acquire Aragon Pharmaceuticals, Inc., a...
Biopharmaceuticals, Mergers & Acquisitions
Johnson & Johnson, Aragon Pharmaceuticals

COLUMBUS, Ohio, June 17, 2013 -- (Healthcare Sales & Marketing Network) -- Minimally Invasive Devices, Inc. (MID) today announced it has raised an additional $2.5 million from Radius Ventures, topping off its Series B financing at $11.5 million. The Serie...
Devices, Surgery, Venture Capital
Minimally Invasive Devices Inc, FloShield, laparoscopic vision system

AUDUBON, Pa.--(Healthcare Sales & Marketing Network)--Globus Medical, Inc. (GMED), a leading spinal implant manufacturer, today announced that the jury in a patent infringement case in the U.S. District Court in Delaware brought by DePuy Synthes Products, ...
Devices, Neurosurgery, Orthopaedic, Litigation
Globus Medical, Synthes , DePuy, DePuy Synthes Products

CentraFLOW Technology Driving Greater Adoption of the ICL Procedure Korea Currently Largest Market for ICL Technology Argentina Market Key to Driving ICL Latin America Growth Nearly 20,000 Successful Implants of Visian ICLs with CentraFLOW Already...
Devices, Ophthalmology, Regulatory
STAAR Surgical, Visian Implantable, Collamer Lens, CentraFLOW

SOUTH SAN FRANCISCO, Calif., June 17, 2013 -- (Healthcare Sales & Marketing Network) -- NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive ...
Biopharmaceuticals, Endocrinology
NGM Biopharmaceuticals, MedImmune, AstraZeneca, diabetes

PRINCETON, N.J. and NANJING, China, June 14, 2013 -- (Healthcare Sales & Marketing Network) -- Bristol-Myers Squibb Company (BMY) and Simcere Pharmaceutical Group (SCR), a leading pharmaceutical company in China, today announced that the companies have ex...
Biopharmaceuticals
Simcere Pharmaceutical, Bristol-Myers Squibb, Orencia, abatacept

PRINCETON, N.J. & NANJING, China--(Healthcare Sales & Marketing Network)--Bristol-Myers Squibb Company (BMY) and Simcere Pharmaceutical Group (SCR), a leading pharmaceutical company in China, today announced that the companies have expanded their strategic...
Biopharmaceuticals
Bristol-Myers Squibb, Simcere Pharmaceutical, Orencia, abatacept

The M22 Is Now the Only Multi-Application System With a True Fractional Non-Ablative Module, Enabling Physicians to Successfully Treat a Broad Range of Skin Conditions BERLIN--(Healthcare Sales & Marketing Network) - Lumenis Ltd., the world's largest me...
Devices, Dermatology, Product Launch
Lumenis, ResurFX, M22, skin resurfacing

PARIS--(Healthcare Sales & Marketing Network)--Ipsen (Euronext: IPN; ADR: IPSEY) (IPN.PA) today announced that, as part of the accelerated execution of its strategy in the USA, the Group adopted a new organizational model for the distribution of Dysport&re...
Biopharmaceuticals, Neurology
Ipsen, Dysport